{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:48:54Z","timestamp":1793134134068,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["americanjournalofsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.amjsurg.2026.116898","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:21:51Z","timestamp":1772497311000},"page":"116898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Active surveillance for low-grade ductal carcinoma in situ: A mixed-methods systematic review of patient, clinician, and health-system perspectives"],"prefix":"10.1016","volume":"256","author":[{"given":"Daniella Hui Xin","family":"Poh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristal Li Yi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyi","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin Xiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8561-2513","authenticated-orcid":false,"given":"Qin Xiang","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serene Si Ning","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.amjsurg.2026.116898_bib1","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/bcr623","article-title":"The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH) \u2013 current definitions and classification","volume":"5","author":"Pinder","year":"2003","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.amjsurg.2026.116898_bib2","first-page":"531","article-title":"Current strategies to reducing interval breast cancers: a systematic review","volume":"17","author":"Goh","year":"2025","journal-title":"Breast Cancer"},{"issue":"5","key":"10.1016\/j.amjsurg.2026.116898_bib3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.6004\/jnccn.2024.0035","article-title":"Breast cancer, version 3.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Gradishar","year":"2024","journal-title":"J Natl Compr Cancer Netw"},{"issue":"12","key":"10.1016\/j.amjsurg.2026.116898_bib4","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/cncr.21069","article-title":"The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up","volume":"103","author":"Sanders","year":"2005","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.amjsurg.2026.116898_bib5","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/jama.2024.26698","article-title":"Active monitoring with or without endocrine therapy for low-risk ductal carcinoma in situ: the COMET randomized clinical trial","volume":"333","author":"Hwang","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.amjsurg.2026.116898_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113276","article-title":"Active surveillance versus treatment in low-risk DCIS: women's preferences in the LORD-trial","volume":"192","author":"Schmitz","year":"2023","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.116898_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.clon.2020.07.007","article-title":"Long-term survival outcomes of \u2018Low Risk\u2019 ductal carcinoma in situ from a territory-wide cancer registry","volume":"33","author":"Co","year":"2021","journal-title":"Clin Oncol"},{"key":"10.1016\/j.amjsurg.2026.116898_bib8","article-title":"Single-arm confirmatory trial of endocrine therapy alone for estrogen receptor-positive, low-risk ductal carcinoma in situ of the breast (JCOG1505, LORETTA trial)","author":"Hiroji","year":"2017","journal-title":"UMIN Clinical Trials Registry"},{"issue":"2","key":"10.1016\/j.amjsurg.2026.116898_bib9","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s12253-019-00760-8","article-title":"Grading Ductal Carcinoma In Situ (DCIS) of the breast \u2013 what's wrong with it?","volume":"26","author":"Cserni","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.amjsurg.2026.116898_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev-med-050715-104920","article-title":"Controversies in the treatment of DCIS","volume":"68","author":"Barrio","year":"2017","journal-title":"Annu Rev Med"},{"issue":"5","key":"10.1016\/j.amjsurg.2026.116898_bib11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.breast.2015.08.004","article-title":"How different terminology for ductal carcinoma in situ (DCIS) impacts women's concern and management preferences: a qualitative study","volume":"24","author":"Nickel","year":"2015","journal-title":"Breast"},{"issue":"6","key":"10.1016\/j.amjsurg.2026.116898_bib12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/15246090152543175","article-title":"Knowledge, satisfaction, and perceived cancer risk among women diagnosed with ductal carcinoma in situ","volume":"10","author":"Bluman","year":"2001","journal-title":"J Womens Health Gend Based Med"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.116898_bib13","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pec.2010.07.002","article-title":"Knowledge, satisfaction with information, decisional con-flict and psychological morbidity amongst women diagnosed with ductal carcinoma in situ (DCIS)","volume":"84","author":"De Morgan","year":"2011","journal-title":"Patient Educ Counsel"},{"issue":"4","key":"10.1016\/j.amjsurg.2026.116898_bib14","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1369-6513.2002.00199.x","article-title":"\"Well, have I got cancer or haven't I?\" Tte psycho-social issues for women diagnosed with ductal carcinoma in situ","volume":"5","author":"De Morgan","year":"2002","journal-title":"Health Expect"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.116898_bib15","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1186\/s13063-023-07703-4","article-title":"Recruiting women with ductal carcinoma in situ to a randomised controlled trial: lessons from the LORIS study","volume":"24","author":"Wheelwright","year":"2023","journal-title":"Trials"},{"issue":"11","key":"10.1016\/j.amjsurg.2026.116898_bib16","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamasurg.2017.2181","article-title":"Factors associated with underestimation of invasive cancer in patients with ductal carcinoma in situ: precautions for active surveillance","volume":"152","author":"Chavez de Paz Villanueva","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.amjsurg.2026.116898_bib17","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.amjsurg.2026.116898_bib18","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.amjsurg.2026.116898_bib19","author":"Blanchard"},{"key":"10.1016\/j.amjsurg.2026.116898_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-079890","article-title":"ROBVALU: a tool for assessing risk of bias in studies about people's values, utilities, or importance of health outcomes","volume":"385","author":"Karam","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.amjsurg.2026.116898_bib22","series-title":"Chapter 8: Mixed Methods Systematic Reviews (2020)","author":"Lizarondo","year":"2024"},{"issue":"16","key":"10.1016\/j.amjsurg.2026.116898_bib23","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.3390\/cancers13163962","article-title":"Preferences of treatment strategies among women with low-risk DCIS and oncologists","volume":"13","author":"Byng","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.amjsurg.2026.116898_bib24","article-title":"Comparing two treatment approaches for women with Ductal Carcinoma In Situ (DCIS) \u2014 the PORTAL study [Internet]","author":"Hwang","year":"2021","journal-title":"Wash Times: Patient-Centered Out-comes Research Institute (PCORI)"},{"key":"10.1016\/j.amjsurg.2026.116898_bib25","series-title":"Preferences of Women in Deciding About Treatment by low-grade DCIS A Hypothetical Preference Study [Thesis]","author":"Geerts","year":"2016"},{"key":"10.1016\/j.amjsurg.2026.116898_bib26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejca.2019.09.026","article-title":"Valuing preferences for treating screen detected ductal carcinoma in situ","volume":"123","author":"Bromley","year":"2019","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.amjsurg.2026.116898_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008094","article-title":"How different terminology for ductal carcinoma in situ impacts women's concern and treatment preferences: a randomised comparison within a national community survey","volume":"5","author":"McCaffery","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.amjsurg.2026.116898_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2024.103764","article-title":"DCIS knowledge of women choosing between active surveillance and surgery for low-risk DCIS","volume":"77","author":"Engelhardt","year":"2024","journal-title":"Breast"},{"key":"10.1016\/j.amjsurg.2026.116898_bib29","article-title":"Non-surgical treatment for ductal carcinoma in situ of the breasts - a prospective study on patient's perspective","volume":"26","author":"Co","year":"2021","journal-title":"Cancer Treat Res Commun"},{"issue":"11","key":"10.1016\/j.amjsurg.2026.116898_bib30","doi-asserted-by":"crossref","first-page":"e1639","DOI":"10.1200\/OP.20.00614","article-title":"Patient preferences for outcomes following DCIS management strategies: a discrete choice experiment","volume":"17","author":"Chapman","year":"2021","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.amjsurg.2026.116898_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.21037\/abs-22-1","article-title":"Data working group national accreditation program for breast centers. Physician's comfort level with observing ductal carcinoma in situ of the breast: a survey of breast specialists at accredited breast centers in the United States","volume":"7","author":"Poli","year":"2023","journal-title":"Ann Breast Surg"},{"issue":"8","key":"10.1016\/j.amjsurg.2026.116898_bib32","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/cncr.34126","article-title":"\"Is it cancer or not?\" A qualitative exploration of survivor concerns surrounding the diagnosis and treatment of ductal carcinoma in situ","volume":"128","author":"Rosenberg","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.amjsurg.2026.116898_bib33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.breast.2020.09.002","article-title":"Views of healthcare professionals about the role of active monitoring in the management of ductal carcinoma in situ (DCIS): qualitative interview study","volume":"54","author":"Nickel","year":"2020","journal-title":"Breast"},{"issue":"3","key":"10.1016\/j.amjsurg.2026.116898_bib34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4274\/ejbh.galenos.2022.2022-4-3","article-title":"The senologic international society survey on ductal carcinoma in situ: present and future","volume":"18","author":"Mathelin","year":"2022","journal-title":"Eur J Breast Health"},{"key":"10.1016\/j.amjsurg.2026.116898_bib35","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.breast.2023.07.012","article-title":"The natural history of ductal carcinoma in situ (DCIS) in simulation models: a systematic review","volume":"71","author":"Poelhekken","year":"2023","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.116898_bib36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41392-024-01779-3","article-title":"Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"23","key":"10.1016\/j.amjsurg.2026.116898_bib37","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1200\/JCO.2009.26.8847","article-title":"Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ","volume":"28","author":"Rudloff","year":"2010","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.amjsurg.2026.116898_bib38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.semradonc.2022.01.005","article-title":"DCIS: risk assessment in the molecular era","volume":"32","author":"Knowlton","year":"2022","journal-title":"Semin Radiat Oncol"},{"issue":"4","key":"10.1016\/j.amjsurg.2026.116898_bib39","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1200\/JCO.2008.16.6215","article-title":"Can women with early-stage breast cancer make an informed decision for mastectomy?","volume":"27","author":"Collins","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjsurg.2026.116898_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjsurg.2025.116642","article-title":"What matters most? Understanding patient preferences in breast cancer treatment: a systematic review of discrete choice experiments","volume":"250","author":"Chua","year":"2025","journal-title":"Am J Surg"},{"issue":"4","key":"10.1016\/j.amjsurg.2026.116898_bib41","first-page":"225","article-title":"Understanding patient decision-making in breast cancer surgery: risk perception, communication, and psychosocial influences","volume":"13","author":"Sbaity","year":"2025","journal-title":"Med Sci"},{"key":"10.1016\/j.amjsurg.2026.116898_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1467738","article-title":"Exploring non-surgical alternatives for low to intermediate-grade in situ ductal carcinoma of the breast using vacuum-assisted excision: the VACIS protocol","volume":"11","author":"Nicosia","year":"2024","journal-title":"Front Med"},{"issue":"12","key":"10.1016\/j.amjsurg.2026.116898_bib43","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.3390\/biomedicines13122987","article-title":"Cryotherapy as a surgical De-Escalation strategy in breast cancer: techniques, complications, and oncological outcomes","volume":"13","author":"Lee","year":"2025","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.amjsurg.2026.116898_bib44","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1158\/2767-9764.CRC-22-0263","article-title":"Identifying good candidates for active surveillance of ductal carcinoma in situ: insights from a large neoadjuvant endocrine therapy cohort","volume":"2","author":"Glencer","year":"2022","journal-title":"Cancer Res Commun"},{"key":"10.1016\/j.amjsurg.2026.116898_bib45","series-title":"Proceedings of the San Antonio Breast Cancer Symposium (SABCS)","article-title":"The single-arm confirmatory trial of tamoxifen alone without surgery for low-risk ductal carcinoma in situ of the breast with ER-positive, HER2-negative (LORETTA trial: JCOG1505)","author":"Iwata","year":"2025"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.116898_bib46","article-title":"Decision aids for people facing health treatment or screening decisions","volume":"1","author":"Stacey","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.amjsurg.2026.116898_bib47","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3390\/healthcare13070748","article-title":"The implementation of shared decision-making using patient decision aid tools to select breast cancer treatment options: a systematic review in the time of minimum quality standards","volume":"13","author":"Lopez-Fernandez","year":"2025","journal-title":"Healthcare"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961026000814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961026000814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:54:29Z","timestamp":1780592069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002961026000814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":46,"alternative-id":["S0002961026000814"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2026.116898","relation":{},"ISSN":["0002-9610"],"issn-type":[{"value":"0002-9610","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Active surveillance for low-grade ductal carcinoma in situ: A mixed-methods systematic review of patient, clinician, and health-system perspectives","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2026.116898","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116898"}}